Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
The American Journal of Pathology|August 29, 2007
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoJeroen T Buijs, Cyrill A Rentsch, Geertje van der Horst, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
Molecular Cell|June 9, 2023
Minor intron splicing is critical for survival of lethal prostate cancerAnke Augspach, Kyle D Drake, Luca Roma, et al.
BJU International|December 18, 2016
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancerPirus Ghadjar, Stefanie Hayoz, Vera Genitsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trialChristina Schröder, Daniel R Zwahlen, Sämi Schär, et al.
The Journal of Urology|April 28, 2025
Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Patients Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy OnlyMarc A Furrer, Niranjan J Sathianathen, Clancy J Mulholland, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinomaG Gakis, T M Morgan, S Daneshmand, et al.
The American Journal of Pathology|August 29, 2007
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoJeroen T Buijs, Cyrill A Rentsch, Geertje van der Horst, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
Molecular Cell|June 9, 2023
Minor intron splicing is critical for survival of lethal prostate cancerAnke Augspach, Kyle D Drake, Luca Roma, et al.
BJU International|December 18, 2016
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancerPirus Ghadjar, Stefanie Hayoz, Vera Genitsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 10, 2025
Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trialChristina Schröder, Daniel R Zwahlen, Sämi Schär, et al.
The Journal of Urology|April 28, 2025
Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Patients Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy OnlyMarc A Furrer, Niranjan J Sathianathen, Clancy J Mulholland, et al.
Pageof 31